Made With Uberflip Content Marketing

Youtube - All Videos

Videos from EBD Group series of life science partnering events and interviews with key opinion leaders across pharma, biotech and investment.

  • BIO-Europe® 2017: Join us in Berlin1:08

    BIO-Europe® 2017: Join us in Berlin

    Don’t miss Europe’s largest annual life science conference in Berlin, November 6–8, 2017. We offer powerful opportunities for you to network with the right partners and bring together hundreds of the

    Watch Video
  • How can startup companies get noticed by potential investors and partners?1:22

    How can startup companies get noticed by potential investors and partners?

    Access the industry's premier life science partnering event, BioPharm America™ in Boston September 26–27, 2017, to connect with strategic partners and get your innovation funded. No other event combin

    Watch Video
  • BIO-Europe Spring® 2017: Producing monoclonals for at least a tenth of the cost8:04

    BIO-Europe Spring® 2017: Producing monoclonals for at least a tenth of the cost

    Dutch antibody technology company BiosanaPharma is offering to make monoclonal antibodies at between 5% and 10% the usual cost of manufacture. Dr. Nettie Buitelaar, the company’s chief business office

    Watch Video
  • BIO-Europe Spring® 2017: Avir BD execs on innovative meds for Canadians4:15

    BIO-Europe Spring® 2017: Avir BD execs on innovative meds for Canadians

    Located in Quebec, Canada, Avir Pharma, a specialty pharma company, is part of the Laboratoire Riva group. Its primary focus is to acquire, license or co-develop innovative medicines with an end aim o

    Watch Video
  • Testimonials highlight opportunities for China cross-border collaboration2:48

    Testimonials highlight opportunities for China cross-border collaboration

    ChinaBio® Partnering Forum 2017 meets May 31–June 1 in Zhuhai, China. Don’t miss the abundant opportunities to engage with the global life science community and forge valuable cross-border partnership

    Watch Video
  • BIO-Europe Spring® 2017: Imanova trims Phase I and IIa trial timelines and costs9:24

    BIO-Europe Spring® 2017: Imanova trims Phase I and IIa trial timelines and costs

    Dr. Kevin Cox, CEO of Imanova, the UK-based translational biomedical imaging company, explains to Scrip’s Mike Ward how his company can help biotechs and pharma firms cut the cost of Phase I and IIa t

    Watch Video
  • BIO-Europe Spring® 2017: Mitochondrial medicine focus drives NeuroVive orphan ambitions9:16

    BIO-Europe Spring® 2017: Mitochondrial medicine focus drives NeuroVive orphan ambitions

    Underpinned by a profound understanding of genetic mitochondrial disorders, Swedish biotech NeuroVive Pharmaceutical AB is pursuing a two-pronged orphan and speciality pharma approach. CEO Erik Kinnma

    Watch Video
  • BIO-Europe Spring® 2017: vitalityDNA plans to keep healthy indviduals healthy9:27

    BIO-Europe Spring® 2017: vitalityDNA plans to keep healthy indviduals healthy

    Precision medicines, an increased interest in the microbiome and a growing focus on wellness are some of the latest trends gripping the healthcare industry. London-based startup vitalityDNA is combini

    Watch Video
  • BIO-Europe Spring® 2017: Ergomed's evolution and risk-sharing business model in practice8:16

    BIO-Europe Spring® 2017: Ergomed's evolution and risk-sharing business model in practice

    Over the last decade Ergomed has evolved from a contract research organization into a clinical-stage drug development company. Chief business officer Andrew Mackie tells Scrip more about this transfor

    Watch Video
  • BIO-Europe Spring® 2017: Noxxon CEO discusses partners and cancer combinations5:09

    BIO-Europe Spring® 2017: Noxxon CEO discusses partners and cancer combinations

    Noxxon CEO Aram Mangasarian talks to Scrip about development plans for the company's lead compound NOX-A12, which is being tested as a combination therapy for a number of cancer indications. NOX-A12 i

    Watch Video
  • BIO-Europe Spring® 2017: Celyad VP talks IP issues, development timelines for CAR-T therapies8:22

    BIO-Europe Spring® 2017: Celyad VP talks IP issues, development timelines for CAR-T therapies

    Georges Rawadi, VP of business development and intellectual property at Celyad, discusses the company's CAR-T pipeline, recently resolved IP issues and the firm's strategy for future clinical developm

    Watch Video
  • BIO-Europe Spring® 2017: TxCell plans first-in-man trial of regulatory T cells9:41

    BIO-Europe Spring® 2017: TxCell plans first-in-man trial of regulatory T cells

    Having completed a Phase I/IIa study of Ovasave, a drug candidate from its first generation non-modified antigen-specific regulatory T cells (Tregs), TxCell expects to start a first-in-man study of a

    Watch Video
  • BIO-Europe Spring® 2017: Genentech's BD head spotlights neuroscience pipeline9:39

    BIO-Europe Spring® 2017: Genentech's BD head spotlights neuroscience pipeline

    Thomas Zioncheck, global head of business development for neuroscience, ophthalmology, and research tools and technology at Genentech, talks to Scrip about the company's early-stage partnering strateg

    Watch Video
  • BIO-Europe Spring® 2017: Sofinnova chairman discusses entrepreneurial culture change in biotech5:47

    BIO-Europe Spring® 2017: Sofinnova chairman discusses entrepreneurial culture change in biotech

    Antoine Papiernik is the chairman of Paris-based Sofinnova Partners, a venture capital firm that invests in startups and spinout biotech companies primarily in Europe. He spoke with Luke Timmerman, th

    Watch Video
  • BIO-Europe Spring® 2017: Chronic constipation device impresses judges in startup competition5:55

    BIO-Europe Spring® 2017: Chronic constipation device impresses judges in startup competition

    usMIMA is a team of scientists and engineers that has developed a solution for chronic constipation. The group won second place in BIO-Europe Spring's 2017 Healthtech Startup competition. MowoOT is fo

    Watch Video
  • BIO-Europe Spring® 2017: Newron CEO on Xadago and upcoming pipeline milestones8:01

    BIO-Europe Spring® 2017: Newron CEO on Xadago and upcoming pipeline milestones

    Newron CEO Stefan Weber discusses the company's Parkinson's therapy, Xadago (safinamide), on the eve of its US market approval during the recent BIO-Europe Spring partnering conference. Newron, a clin

    Watch Video
  • BIO-Europe Spring® 2017: Partnerships are key for rare disease drug discovery and development8:00

    BIO-Europe Spring® 2017: Partnerships are key for rare disease drug discovery and development

    What kinds of partnerships are key to getting rare disease research out of the lab and to patients as therapies and cures? Wendy White, Board Chairman of Global Genes, discusses her work on behalf of

    Watch Video
  • BIO-Europe Spring® 2017: Atriva repurposes cancer drug candidates to create universal flu treatment11:27

    BIO-Europe Spring® 2017: Atriva repurposes cancer drug candidates to create universal flu treatment

    Dr. Rainer Lichtenberger, CEO of Atriva Therapeutics, a 2015 startup, explains to Mike Ward, head of pharma content at Informa Pharma Intelligence, how his company is taking kinase inhibitors original

    Watch Video
  • BIO-Europe Spring® 2017: Venneos develops next generation label-free cell analysis6:15

    BIO-Europe Spring® 2017: Venneos develops next generation label-free cell analysis

    Cell-based assays play a crucial role in drug discovery, toxicity testing and have the potential to contribute new insights into cellular behavior. However, many have limitations such as requiring lab

    Watch Video
  • BIO-Europe Spring® 2017: Biomunex CEO on earlier deals for cancer drugs7:00

    BIO-Europe Spring® 2017: Biomunex CEO on earlier deals for cancer drugs

    During the recent BIO-Europe Spring partnering conference in Barcelona, Biomunex CEO Pierre-Emmanuel Gerard chats with Scrip about the company's strategy for partnering with pharmas in the cancer drug

    Watch Video
  • loading
    Loading More...